Rankings
▼
Calendar
PHIO Q1 2017 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$1M
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-15786.00
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$114,000
Balance Sheet
Total Assets
$11M
Total Liabilities
$2M
Stockholders' Equity
$8M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$10,000
-100.0%
Gross Profit
-$1M
-$1M
-4.0%
Operating Income
-$5M
-$2M
-143.2%
Net Income
-$5M
-$2M
-144.7%
← FY 2017
All Quarters
Q2 2017 →